NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.
Quick Stats
Jul 07, 202657.5
AI Score
HOLD0.78
Volume Ratio
Aug 05, 2026
Next Earnings
16
+ve Days (30d)
14
-ve Days (30d)
NAMS Stock Summary
Last updated Jul 07, 2026
NAMS is currently trading at $36.99, positioned above its 200-day moving average of $33.73, indicating a long-term uptrend. The stock has a 52-week range of $19.22 to $42.205.
Technical Analysis: The 50-day moving average stands at $32.9, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 68.885, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.076, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates NAMS at 57.5/100 with a HOLD recommendation.
NAMS (NewAmsterdam Pharma Company N.V. Ordinary Shares) Indicators
Last updated Jul 07, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 68.885 |
| CMF (20) | 0.076 |
| ROC (10) | 20.019 |
| ADX (14) | 20.872 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.724 |
| AROONOSC (14) | 92.857 |
| WILLAMS %R (14) | -4.592 |
| MFI (14) | 66.161 |
NAMS Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
NAMS Price vs Max Options Open Interest
NAMS Max Change In Options Open Interest
NAMS Options - Sort by Max open Interest (near term)
8th July 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NAMS Daily Out of Money Options - Sort by Max open Interest (near term)
8th July 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NAMS Daily In the Money Options - Sort by Max open Interest (near term)
8th July 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NAMS Most Active Options by Volume(near term)
8th July 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
NewAmsterdam Pharma Company N.V. Ordinary Shares is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
NAMS Moving Averages Analysis
NewAmsterdam Pharma Company N.V. Ordinary Shares has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jul 07, 2026
NewAmsterdam Pharma Company N.V. Ordinary Shares has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jul 07, 2026
NAMS (NewAmsterdam Pharma Company N.V. Ordinary Shares) Simple Moving Averages
Moving Averages are last updated Jul 07, 2026
| Days | MA |
|---|---|
| 10 | 33.86 |
| 20 | 32.08 |
| 30 | 32.62 |
| 50 | 32.9 |
| 100 | 32.76 |
| 200 | 33.73 |
NAMS Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 4.1 billion |
| Earnings/Share ($) | -1.78 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -1.5883 |
| EPS Estimate Next Year ($) | -1.3191 |
| WallStreet Target Price ($) | 49.6839 |
| Most Recent Quarter |